Skip to search boxSkip to navigationSkip to main content

Effect of preterm birth on growth and blood pressure in adulthood in the Pelotas 1993 cohort

  • Winok Lapidaire
    ,
  • Alvaro Proaño
    ,
  • Cauane Blumenberg
    ,
  • ,
  • Carlos A. Delgado
    ,
  • Darwin Del Castillo
*Corresponding author for this work
  • University of Oxford Medical Sciences Division
    ,
  • Children’s Hospital of Philadelphia
    ,
  • Tulane University School of Medicine
    ,
  • Programa de Pós-Graduação em Epidemiologia da Universidade Federal de Pelotas (UFPel)
    ,
  • Universidade Federal do Rio Grande
    ,
  • Causale Consultoria
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1870-1877 (8 pages)

Journal (Volume, Issue Number)

International Journal of Epidemiology (Volume 52, Issue 6)

Publication milestones

  • Published - 01/12/2023

Publication status

Published - 01/12/2023

ISSN

0300-5771

Publication IDs

  • Scopus: 85180667557
  • PubMed: 37354551

Abstract

Background: Preterm birth has been associated with increased risk of hypertension and cardiovascular disease later in adulthood, attributed to cardiovascular and metabolic alterations in early life. However, there is paucity of evidence from low-and middle-income countries (LMICs). Methods: We investigated the differences between preterm (<37 weeks gestational age) and term-born individuals in birth length and weight as well as adult (18 and 20 years) height, weight and blood pressure in the Brazilian 1993 Pelotas birth cohort using linear regressions. Analyses were adjusted for the maternal weight at the beginning of pregnancy and maternal education and family income at childbirth. Additional models were adjusted for body mass index (BMI) and birthweight. Separate analyses were run for males and females. The complete sample was analysed with an interaction term for sex. Results: Of the 3585 babies included at birth, 3010 were followed up in adulthood at 22 years. Preterm participants had lower length and weight at birth. This difference remained for male participants in adulthood, but female participants were no shorter than their term counterparts by 18 years of age. At 22 years, females born preterm had lower blood pressures (systolic blood pressure-1.00 mmHg, 95%CI-2.7, 0.7 mmHg; diastolic blood pressure-1.1 mmHg, 95%CI-2.4, 0.3 mmHg) than females born at term. These differences were not found in male participants. Conclusions: In this Brazilian cohort we found contrasting results regarding the association of preterm birth with blood pressure in young adulthood, which may be unique to an LMIC.

Funding Details

This article is based on data from the study ‘Pelotas Birth Cohort, 1993’ conducted by the Postgraduate Program in Epidemiology at Universidade Federal de Pelotas with the collaboration of the Brazilian Public Health Association (ABRASCO). From 2004 to 2013, the Wellcome Trust supported the 1993 birth cohort study. The European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq) and the Brazilian Ministry of Health supported previous phases of the study. The 22-year follow-up was supported by the Science and Technology Department/Brazilian Ministry of Health, with resources transferred through the Brazilian National Council for Scientific and Technological Development (CNPq), grant 400943/2013–1. W.L. is funded by a Lee Hysan Junior Research Fellowship from St Hilda's College, Oxford. C.A.D. acknowledges the support received from: the National Fund for Scientific, Technological Development and Innovation—FONDECYT (grant number 033–2019); Stars in Global Health, Round 8 (2016): Reproductive, Maternal, Newborn and Child Health; Grand Challenges Canada (grant number R-ST-POC-1707–06330); the National Fund for Scientific, Technological Development and Innovation (Contract No. 053–2014-FONDECYT) in association with Grand Challenges Canada (GCC, Grant S7 0690–01-10); and Collaborative Projects Fund (R.D. N 501–2015-INSN-DG-OEA) granted by the Instituto Nacional de Salud del Niño, Lima, Peru. A.J.L. is funded by a British Heart Foundation Intermediate Research Fellowship (FS/18/3/33292). J.J.M. acknowledges having received support from the Alliance for Health Policy and Systems Research (HQHSR1206660), Bloomberg Philanthropies (grant 46129, via University of North Carolina at Chapel Hill School of Public Health), the National Fund for Scientific and Technological Development via CIENCIACTIVA/CONCYTEC, British Council, British Embassy and the Newton-Paulet Fund (223–2018, 224–2018), Department for International Development/Medical Research Council/Wellcome Global Health Trials (MR/M007405/1), Fogarty International Center (R21TW009982, D71TW010877, R21TW011740), Grand Challenges Canada (0335–04), International Development Research Center Canada (IDRC 106887, 108167), Inter-American Institute for Global Change Research (IAI CRN3036), National Cancer Institute (1P20CA217231), National Heart, Lung and Blood Institute (HHSN268200900033C, 5U01HL114180, 1UM1HL134590), National Institute of Mental Health (1U19MH098780), Swiss National Science Foundation (40P740-160366), UK Research and Innovation Biotechnology and Biological Sciences Research Council (BB/T009004/1), UK Research and Innovation Engineering and Physical Sciences Research Council (EP/V043102/1), UK Research and Innovation Medical Research Council (MR/P008984/1, MR/P024408/1, MR/P02386X/1), Wellcome (074833/Z/04/Z, 093541/Z/10/Z, 103994/Z/14/Z, 107435/Z/15/Z, 205177/Z/16/Z, 214185/Z/18/Z, 218743/Z/19/Z) and the World Diabetes Foundation (WDF15-1224).
FundersFunding numbers
British Embassy
223–2018
Collaborative Projects Fund
N 501–2015-INSN-DG-OEA
Department for International Development/Medical Research Council/Wellcome Global Health Trials
MR/M007405/1
Instituto Nacional de Salud del Niño
-
National Fund for Scientific, Technological and Technological Innovation Development
033–2019
St Hilda's College, Oxford
-
UK Research and Innovation Biotechnology and Biological Sciences Research Council
BB/T009004/1
UK Research and Innovation Engineering and Physical Sciences Research Council
EP/V043102/1
UK Research and Innovation Medical Research Council
MR/P02386X/1, MR/P008984/1, MR/P024408/1
University of North Carolina at Chapel Hill School of Public Health
-
NIMH
1U19MH098780
NHLBI
5U01HL114180, HHSN268200900033C, 1UM1HL134590
NCI
1P20CA217231
FIC
R21TW011740, 0335–04, R21TW009982, D71TW010877
AHPSR
46129, HQHSR1206660
WT
107435/Z/15/Z, 205177/Z/16/Z, 218743/Z/19/Z, 214185/Z/18/Z, 074833/Z/04/Z, 093541/Z/10/Z, 103994/Z/14/Z
IDRC
108167, 106887
BHF
FS/18/3/33292
British Council
-
EC
-
SNF
40P740-160366
FONDECYT
-
CNPq
400943/2013–1
Guizhou Provincial Science and Technology Department
-
GCC
R-ST-POC-1707–06330, S7 0690–01-10, 053–2014-FONDECYT
Ministério da Saúde
-
CONCYTEC
-
FONDECYT
-
IAI
IAI CRN3036
WDF
WDF15-1224

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Mentions
1
Captures
41
Citations
2

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well